Exploring Diabetes Technology Advancements in 2023: A Year in Review | Recording-Exploring Diabetes Technology Advancements in 2023: A Year in Review

Video Transcription

Video Summary

In this webinar, Dr. Akturk and Dr. Welch discuss the newest advancements in diabetes technology. They review the Tempo Smart Pen, a specialized insulin pen that communicates with an app via Bluetooth. The pen can recognize which type of insulin it is attached to and how many units of insulin are given at a time. It also offers insulin reminders, can take pictures of food to estimate carbohydrate intake, and has a glucose meter that can communicate with the app. Dr. Welch also discusses the Dexcom G7, a continuous glucose monitoring (CGM) system that does not require calibration and has a shorter warm-up time compared to previous models. He highlights the integration of the Dexcom G7 with insulin pumps and the improved accuracy of the CGM over time. Dr. Everett discusses the Medtronic 780G, a hybrid closed-loop insulin pump system that uses the Guardian 4 sensor. She also discusses the Ilet Bionic Pancreas, which uses the Dexcom G6 algorithm and requires minimal user input. Finally, she discusses the Tandem MOBI, the world's smallest insulin delivery system that is operated through an app on an iPhone. In terms of choosing which system to use, both doctors emphasize the importance of shared decision-making and considering the patient's lifestyle and preferences. They also address the use of these technologies in primary care and the inpatient setting. Overall, these advancements in diabetes technology provide patients with more options for managing their condition and improving their quality of life.

Keywords

diabetes technology

Tempo Smart Pen

insulin pen

Dexcom G7

continuous glucose monitoring

CGM

Medtronic 780G

hybrid closed-loop insulin pump

Ilet Bionic Pancreas

Tandem MOBI